The sFlt-1/PlGF ratio did not effectively gauge future preeclampsia risk in pregnant patients with SLE and proteinuria.

Though the strategic shift allows pharma to offer integrated health solutions, diversify revenue and improve patient outcomes ...

Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, ...

AstraZeneca (GB:AZN) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top Wall Street ...

It’s been a good year for both the Footsie and the S&P 500. But Mark Hartley explains why he’d rather consider UK shares for ...

London’s FTSE 100 index is set to open 17 points higher at 8081, despite the weak handover from Wall Street’s poor ...

CHICAGO -- Researchers failed to prevent cognitive impairment in people with existing atrial fibrillation (Afib) by going the ...

Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low ...

Energy and sustainability are some other areas Swedish firms hope to gain traction in. Read more at straitstimes.com.

A key deadline has passed in the $1 billion realtor settlement, but it is still possible to claim a share of the payout.